10 Things You Should NEVER Do on Retatrutide (ruins it’s benefits)

Key wellness strategies / self-care & productivity-adjacent tips (from the video: Retatrutide “mistakes”)

The speaker (Dr. Jones DC) frames Retatrutide issues as coming from treating it like other GLP-1s (especially semaglutide / tirzepatide), rather than as a triple-agonist that can increase metabolism and change body composition dynamics.

1) Don’t under-eat on Retatrutide (“GLP-1 crash” prevention)

• Eat enough, even if appetite is suppressed.
• If you undereat for long periods, expect symptoms such as:
  • brain fog, exhaustion
  • slowed metabolism / “battery saving mode”
  • hair thinning
• Strategic fix: prioritize protein to fuel function (not just rely on appetite suppression).

2) Don’t copy tirzepatide dosing—find your lowest effective dose

• Don’t assume dosing transfers dose-for-dose from tirzepatide.
• Start lower (speaker’s clinic approach: often ~1–1.5 mg, not 2.5 mg).
• Titrate slowly to find:
  • the lowest effective dose (“therapeutic sweet spot”)
  • fewer side effects (nausea, fatigue)

3) Track heart rate and heat/thermogenic symptoms (safety monitoring)

• Retatrutide may elevate:
  • resting heart rate
  • body temperature / overheating sensations
• Don’t ignore it—monitor and tell your provider.
• If the elevation is significant:
  • dose may be held or the protocol changed
  • in serious cases, Retatrutide may be paused

4) Recalibrate expectations about cravings

• Retatrutide may suppress appetite, but may not “silence food chatter” as strongly as tirzepatide for some people.
• The speaker suggests cravings can differ due to receptor profile:
  • tirzepatide: GLP-1 + GIP (often stronger subjective craving reduction)
  • Retatrutide: GLP-1 + GIP + glucagon (more fat mobilization/metabolic effects)
• Don’t judge Retatrutide only by the “cravings = gone” standard.

5) Don’t chase a “switch flip” by escalating quickly

• Early lack of dramatic appetite shutdown can tempt people to increase dose repeatedly.
• The speaker warns this is riskier because:
  • side effects and metabolic/heart-rate stress can stack across three receptor pathways
• Goal: patience + monitoring, not weekly dose chasing.

6) Don’t measure success only by the scale (track recomposition)

Retatrutide may support body recomposition:

• losing fat while preserving muscle

Scale weight may stall if fat loss/tissue changes don’t show immediately.

Track instead:

• waist measurements
• progress photos
• clothing fit
• body fat % where possible

7) Be cautious with stacking—don’t combine without safety knowledge

• Stacking Retatrutide with other peptides can create receptor stimulation patterns that weren’t well studied together.
• Examples mentioned:
  • stacking Retatrutide with tirzepatide (more GLP-1/GIP + glucagon combined)
  • combinations involving cagrilintide (an amylin analog)
  • “pre-mixed vials” that lock you into a fixed ratio
• Speaker stance: stacking can be strategic, but should be receptor-aware and monitored (not panic-driven guessing).

8) Don’t over-exercise to “maximize the window”

Overtraining can recreate the same “crash” dynamic:

• if your metabolism is already elevated, extra output can push you into energy deficit/down-regulation

Better approach:

• moderate, consistent training 3–4 days/week
• prioritize resistance training to protect muscle mass

9) Don’t quit cold turkey—plan an exit/maintenance strategy

Stopping abruptly can cause:

• appetite rebound
• faster weight regain due to a “steeper metabolic cliff”

Strategy: build maintenance from the start (“metabolic independence”)

• taper / microdosing approach
• maintain via lifestyle habits:
  • strength training
  • nutrition
  • fasting approach
  • stress/sleep optimization

10) Root principle: don’t treat Retatrutide like a simple GLP-1

Overarching conclusion: Retatrutide demands different management because of:

• three-receptor effects
• cardiac/heart-rate monitoring considerations
• recomposition dynamics
• steeper change when stopping
• added complexity with stacking

Core recommendation: professional supervision, tracking more than weight, and adjusting titration based on response.

---

Presenters / sources

• Dr. Jones, DC (speaker/coach; GLP-1 optimization and “Retatrutide optimization strategies” educator)
• Clinic experience / patient outcomes (described by the speaker; no external named studies cited in the subtitles)